Related Experiment Video
Updated: Feb 1, 2026

Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
Published on: April 9, 2019
Cardiodynamic evaluation of sorfequiline (TBAJ-876): results from a first-in-human study
Borje Darpo1, Jerry Nedelman2, Rebecca Bruning-Barry3
1Clario, Philadelphia, Pennsylvania, USA.
Abstract:
Sorfequiline (TBAJ-876) is a novel diarylquinoline under development for tuberculosis. In a first-in-human, multiple-ascending-dose study, electrocardiogram and pharmacokinetic data were analyzed to assess cardiac repolarization. Placebo-corrected change-from-baseline in QTcF (ΔΔQTcF) ranged from -11.4 to +2.4 ms without dose dependency. Concentration-QTc modeling showed a shallow, non-significant slope. The predicted mean effect on ΔΔQTcF at the maximum geometric mean Cmax of sorfequiline's M3 metabolite was -1.1 ms (90% CI -9.5 to 7.4).CLINICAL TRIALSThis study is registered with ClinicalTrials.gov as NCT06058299.
More Related Videos
Related Concept Videos
Case Studies
Self-Evaluation: Self-Enhancement and Self-Verification
Nursing Evaluation
Self-Evaluation Maintenance Model
Dysrhythmias V: Evaluating Dysrhythmias
Biodiversity and Human Values

